Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
  • Donate
0

Newsletters

Sign up to receive our newsletter in your inbox.



Newsletter cover image

Newsletter: April 2021

April 2021: A Historic Month for Psychedelic Science April 28, 2021 Dear friends and supporters, April is a historic month for psychedelic science. On April 19, we celebrated Bicycle Day, a curated event …
Newsletter cover image

Newsletter: March 2021

First Controlled Trial of Cannabis for the Treatment of PTSD Raises No Safety Concerns, Further Research is Needed to Determine Efficacy MAPS Bulletin: Winter 2021 now available online and celebrating …
Newsletter cover image

Newsletter: February 2021

Join the Psychedelic Movement Today Career opportunities, call for suggestions, study recruitment, and more February 26, 2021 Dear friends and supporters, Calling all fans of MAPS! We need your support …
Newsletter cover image

Newsletter: January 2021

Visions for a Successful 2021 Expanding MAPS with new jobs and research January 27, 2021 Dear friends and supporters, As we transition into a new year, MAPS is increasingly thankful for the consistent …
Newsletter cover image

Newsletter: December 2020

MAPS and MAPS Public Benefit Corporation Announce Positive Result from Phase 3 Trial of MDMA-Assisted Therapy for PTSD MAPS-Sponsored Pilot Study Shows MDMA-Assisted Therapy for PTSD in Couples Can Reduce …
Newsletter cover image

Newsletter: November 2020

Study Results: MDMA-Assisted Therapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study November 30, 2020 Dear friends …
Newsletter cover image

Newsletter: October 2020

Study Shows MDMA-Assisted Therapy Will Be Cost-Effective in the Treatment of PTSD Cooperative Research and Development Agreement (CRADA) Signed Between Bronx Veterans Affairs (VA) and MAPS for Phase 2 …
Newsletter cover image

Newsletter: September 2020

MAPS Bulletin Summer 2020: Research Edition Now Available Online September 29, 2020 Dear friends and supporters, As psychedelic research continues to expand at a rapid rate, our organization continues …
Newsletter cover image

Newsletter: August 2020

MAPS Completes $30 Million Capstone Campaign August 29, 2020 Dear friends and supporters, This month, we officially completed the $30 million Capstone Campaign! In just 70 days and well before our September …
Newsletter cover image

Newsletter: July 2020

Capstone Challenge Over Halfway Complete July 31, 2020 Dear friends and supporters, The ongoing Capstone Challenge is the most important fundraising initiative in MAPS’ 34-year history as a non-profit …
Newsletter cover image

Newsletter: June 2020

Capstone Challenge: Help MAPS Meet $10 Million Challenge Grant by September 10 June 30, 2020 Dear friends and supporters, We’re inspired by the outpouring of support we have received for the $10 million …
Newsletter cover image

Newsletter: May 2020

MAPS Continues to Expand: New Job Opportunities Available Interim Analysis Shows At Least 90% Chance of Statistically Significant Difference in PTSD Symptoms after MDMA-Assisted Therapy May 23, 2020 Dear …

Posts navigation

Previous Page Page 1 Page 2 … Page 18 Next Page
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



Login

© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117. All Rights Reserved. Proudly powered by WordPress. Hosted by Pressable